Copays, coinsurance & deductibles may apply
Nanoencapsulation of gallic acid and evaluation of its cytotoxicity and antioxidant activity

#PharmaNews #PharmaPatent #BiotechPatent #NPPA #DPCO #NLEM #PharmaLaw #Pharmacoregulatory #IndianLaw #LatestNews To view or add a comment, sign in Malaysia opens pathway for cannabis-based medical products The Ministry of Health Malaysia has officially opened the door for companies and researchers to register cannabis-based products for medical use Applicants must provide sufficient scientific evidence proving the safety, quality, and efficacy of cannabis-derived compounds before approval Cannabis remains regulated under the Dangerous Drugs Act 1952 and the Poisons Act 1952 meaning strict compliance with existing drug and poison control laws is required The decision does not legalize recreational use but creates a regulated route for scientifically validated cannabis formulations to enter the healthcare system The announcement came through a written parliamentary reply by Dr Kelvin Yii Lee Wuen who asked if medical marijuana would be allowed in Malaysia The Ministry confirmed that all activities related to importation, sale, possession, or supply of cannabis remain prohibited unless authorized for approved medical or research purposes

Materials and methods The Indian Agriculture Research Institute (IARI) in New Delhi, India, provided seeds of the Pusa Sheetal cv
The triple receptor mechanism that makes Retatrutide so effective also means the body cannot easily develop resistance the way it might with single-target medications
Both semaglutide and dulaglutide are available in India on prescription